Details of Fund Raising

Mode of Fund Raising: Preferential Issue

Key Dates:

  • Date of Allotment of Warrants (Equity convertible Warrants): October 30, 2024.
  • Date of Allotment of Equity Shares (Pursuant to conversion of Warrants): December 01, 2025.

Funds Raised:

1. On Warrant Allotment (Oct 30, 2024): The company allotted 19,33,324 warrants at an issue price of ₹45 per warrant (including a premium of ₹35). Allottees paid 25% of the issue price upfront, amounting to ₹11.25 per warrant. The total amount received was ₹2,17,49,895.

2. On Equity Share Allotment (Dec 1, 2025): Pursuant to the conversion of warrants, the company allotted 19,33,324 equity shares at the same issue price of ₹45 per share (including a premium of ₹35). The remaining 75% of the issue price, amounting to ₹33.75 per warrant, was paid. The total amount received in this tranche was ₹6,52,49,685.

Total Amount Raised: ₹8,69,99,580 (Rupees Eight Crore Sixty Nine Lakh Ninety Nine Thousand Five Hundred and Eighty Only).

Objects of the Fund Raise

The proceeds were raised to meet the working capital requirement, fund business expansion, and for other general corporate purposes of the company.

Utilization of Funds and Deviation Statement

Report Filed for Quarter Ended: June 30, 2026

Is there a Deviation/Variation in use of funds raised? Not Applicable

Comments of the Audit Committee: None

Comments of the Auditors: None

Fund Utilization Status:

  • Total Fund Allocated: ₹8,69,99,580
  • Total Fund Utilized till June 30, 2026: ₹8,69,96,580
  • Balance Fund Available: ₹3,000

The company confirms there has been no deviation or variation from the stated objects for which the funds were raised.

Compliance Officer

The disclosure was signed and submitted by Arti Lalwani, Company Secretary and Compliance Officer (Membership no. A59871).